Mountain Hill Investment Partners Corp. Biogen Inc. Transaction History
Mountain Hill Investment Partners Corp.
- $98.2 Billion
- Q4 2024
A detailed history of Mountain Hill Investment Partners Corp. transactions in Biogen Inc. stock. As of the latest transaction made, Mountain Hill Investment Partners Corp. holds 150 shares of BIIB stock, worth $20,908. This represents 0.02% of its overall portfolio holdings.
Number of Shares
150Holding current value
$20,908% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
999Shares Held
130MCall Options Held
1.12MPut Options Held
1.47M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.33 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.24 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.03 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.02 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$715 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...